293 related articles for article (PubMed ID: 8202499)
1. Opsins with mutations at the site of chromophore attachment constitutively activate transducin but are not phosphorylated by rhodopsin kinase.
Robinson PR; Buczyłko J; Ohguro H; Palczewski K
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5411-5. PubMed ID: 8202499
[TBL] [Abstract][Full Text] [Related]
2. Constitutively active mutants of rhodopsin.
Robinson PR; Cohen GB; Zhukovsky EA; Oprian DD
Neuron; 1992 Oct; 9(4):719-25. PubMed ID: 1356370
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of opsin: interaction of mutants with rhodopsin kinase and arrestin.
Rim J; Oprian DD
Biochemistry; 1995 Sep; 34(37):11938-45. PubMed ID: 7547930
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of phototransduction by K296E opsin is not a cause of photoreceptor degeneration.
Li T; Franson WK; Gordon JW; Berson EL; Dryja TP
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3551-5. PubMed ID: 7724596
[TBL] [Abstract][Full Text] [Related]
5. Light-stable rhodopsin. II. An opsin mutant (TRP-265----Phe) and a retinal analog with a nonisomerizable 11-cis configuration form a photostable chromophore.
Ridge KD; Bhattacharya S; Nakayama TA; Khorana HG
J Biol Chem; 1992 Apr; 267(10):6770-5. PubMed ID: 1532391
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylation of bovine opsin and its cysteine mutants in COS cells.
Karnik SS; Ridge KD; Bhattacharya S; Khorana HG
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):40-4. PubMed ID: 8419942
[TBL] [Abstract][Full Text] [Related]
7. Role of the C9 methyl group in rhodopsin activation: characterization of mutant opsins with the artificial chromophore 11-cis-9-demethylretinal.
Han M; Groesbeek M; Smith SO; Sakmar TP
Biochemistry; 1998 Jan; 37(2):538-45. PubMed ID: 9425074
[TBL] [Abstract][Full Text] [Related]
8. A naturally occurring mutation of the opsin gene (T4R) in dogs affects glycosylation and stability of the G protein-coupled receptor.
Zhu L; Jang GF; Jastrzebska B; Filipek S; Pearce-Kelling SE; Aguirre GD; Stenkamp RE; Acland GM; Palczewski K
J Biol Chem; 2004 Dec; 279(51):53828-39. PubMed ID: 15459196
[TBL] [Abstract][Full Text] [Related]
9. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness.
Rao VR; Cohen GB; Oprian DD
Nature; 1994 Feb; 367(6464):639-42. PubMed ID: 8107847
[TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of opsin by mutation of methionine 257 on transmembrane helix 6.
Han M; Smith SO; Sakmar TP
Biochemistry; 1998 Jun; 37(22):8253-61. PubMed ID: 9609722
[TBL] [Abstract][Full Text] [Related]
11. Vertebrate opsins belonging to different classes vary in constitutively active properties resulting from salt-bridge mutations.
Nickle B; Wilkie SE; Cowing JA; Hunt DM; Robinson PR
Biochemistry; 2006 Jun; 45(23):7307-13. PubMed ID: 16752919
[TBL] [Abstract][Full Text] [Related]
12. Opsin/all-trans-retinal complex activates transducin by different mechanisms than photolyzed rhodopsin.
Jäger S; Palczewski K; Hofmann KP
Biochemistry; 1996 Mar; 35(9):2901-8. PubMed ID: 8608127
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of activation and inactivation of opsin: role of Glu113 and Lys296.
Cohen GB; Oprian DD; Robinson PR
Biochemistry; 1992 Dec; 31(50):12592-601. PubMed ID: 1472495
[TBL] [Abstract][Full Text] [Related]
14. Rhodopsin mutants discriminate sites important for the activation of rhodopsin kinase and Gt.
Shi W; Osawa S; Dickerson CD; Weiss ER
J Biol Chem; 1995 Feb; 270(5):2112-9. PubMed ID: 7836439
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of a novel retinylamine analog inhibitor of constitutively active rhodopsin mutants found in patients with autosomal dominant retinitis pigmentosa.
Yang T; Snider BB; Oprian DD
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13559-64. PubMed ID: 9391065
[TBL] [Abstract][Full Text] [Related]
16. Transducin activation by rhodopsin without a covalent bond to the 11-cis-retinal chromophore.
Zhukovsky EA; Robinson PR; Oprian DD
Science; 1991 Feb; 251(4993):558-60. PubMed ID: 1990431
[TBL] [Abstract][Full Text] [Related]
17. Deletion of GRK1 causes retina degeneration through a transducin-independent mechanism.
Fan J; Sakurai K; Chen CK; Rohrer B; Wu BX; Yau KW; Kefalov V; Crouch RK
J Neurosci; 2010 Feb; 30(7):2496-503. PubMed ID: 20164334
[TBL] [Abstract][Full Text] [Related]
18. Assays for activation of opsin by all-trans-retinal.
Sachs K; Maretzki D; Hofmann KP
Methods Enzymol; 2000; 315():238-51. PubMed ID: 10736706
[TBL] [Abstract][Full Text] [Related]
19. Characterization of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Mutations on the cytoplasmic surface affect transducin activation.
Min KC; Zvyaga TA; Cypess AM; Sakmar TP
J Biol Chem; 1993 May; 268(13):9400-4. PubMed ID: 8486634
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the mutant visual pigment responsible for congenital night blindness: a biochemical and Fourier-transform infrared spectroscopy study.
Zvyaga TA; Fahmy K; Siebert F; Sakmar TP
Biochemistry; 1996 Jun; 35(23):7536-45. PubMed ID: 8652533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
